View Document Preview and Link Document Date: 2014-08-01 17:21:22 Open Document File Size: 986,87 KB Share Result on Facebook
City Orlando / Bristol / / Company Medicare Advocacy Inc / Eli Lilly / Pfizer / Omnicare / Johnson and Johnson / AstraZeneca / / Currency USD / / Event FDA Phase / / Facility pharmacy AstraZeneca Seroquel Kickbacks / / IndustryTerm chemical restraints / federal law / overmedication/chemical restraints / / MedicalCondition Alzheimer’s Disease/Dementia / pneumonia / Alzheimer’s disease / uncontrolled tremors / schizophrenia / dementia / hallucinations / cognitive impairment / dyskinesia / heart attack Diabetes Lethargy / heart failure / Atypical Antipsychotics Hallucinations / restlessness / infections / bipolar disorder / / MedicalTreatment physical restraints / / NaturalFeature Kern Valley / / Organization Long Term Care Community Coalition / Food and Drug Administration / Columbia University Psychiatry Department / FDA / Department of Health / Center for Medicare Advocacy / / Person Karlin Mbah / Jeffrey A. Lieberman / Toby Edelman / / Position California State Attorney General / Director of Nursing / nursing director Director / Chief Pharmacist / Administrator / Medical Director / and Nursing Director / Chair / / Product Antipsychotic Drug / Risperdal / Seroquel / Haldol / Geodon / Abilify / Antipsychotic medication / Zyprexa / use / / ProgrammingLanguage FL / / ProvinceOrState California / / SocialTag 
Inappropriate Use of Anti-Psychotics in Nursing Homes: Issues and Advocacy Toby Edelman, Center for Medicare Advocacy, Inc Karlin Mbah, FRIA: The Voice and Resource for Quality Long Term Care Richard Mollot, Long Term Ca